1. Home
  2. > Pharmaceutical
  3. > Therapy Market Trends
Global Home Infusion Therapy Market (By Product, Application, Region), Impact of COVID-19, Key Company Profiles, Trends and Recent Developments - Forecast to 2028

Global Home Infusion Therapy Market (By Product, Application, Region), Impact of COVID-19, Key Company Profiles, Trends and Recent Developments - Forecast to 2028

  • October 2022
  • 165 pages
  • ID: 6328556
  • Format: PDF
  • Igate Research

Summary

Table of Contents

Search Inside

The global home infusion therapy market is predicted to reach US$ 53.2 Billion by 2028. Home infusion therapy is a process of subcutaneous or intravenous administration of biologicals or drugs to a person at home. Home infusion therapy offers various benefits such as cost-effective, convenient, offer better outcomes, and have higher safety standards. Various government programs are being implemented to shift patients towards home care and reduce the overall hospitalization and treatment costs. Additionally, the rise in preference for homecare among patients, particularly for infusion treatment, and the growing developments in infusion healing devices designed for home usage are some of the key factors anticipated to fuel the market growth. Moreover, the growing geriatric population and increasing prevalence of cancer, Crohn’s disease, multiple sclerosis, nutritional and immune deficiencies, dehydration, and nausea & vomiting are major factors driving the market growth. Many home infusion service providers, such as Option Care Health Inc., are working in collaboration with hospitals to facilitate the shift of patients at home care settings to receive treatment, thus driving market growth.

Impact of COVID-19 on Global Home Infusion Therapy Market

The COVID–19 outbreak has become a global stress test. As the number of people infected with the virus continues to rise around the world, uncertainties about global economic growth increases. The COVID–19 disease has infected over 627 million people worldwide. Globally the death toll has reached 6,562,012 according to the latest statistics from the Worldometers. The number is still growing, and the duration of the pandemic is still difficult to predict.

The COVID-19 pandemic had a positive impact on the home infusion therapy market. Major market players reported a notable growth in their revenues from home infusion therapy business segment as the number of patients receiving care from homecare settings surged amid stay-at-home orders. For instance, in 2020, Option Care Health, Inc. saw over 30% rise in revenue due to increased demand for home infusion therapy services. Additionally, Arkansas-based Delta Medical Infusion witnessed 50% increase in their patient load for home infusion therapy services as compared to the previous year. Thus, the COVID-19 pandemic has increased the importance and demand for medical devices especially in a home-based setting as the virus is transmitted through physical contact.

Global Home Infusion Therapy Market – Recent Developments
• In April 2022, CarepathRx, a US-based pharmacy, and medication management solutions, partnered with Mount Sinai Health System, a US-based hospital network. This partnership allows expanding patient access to home infusion therapies across the Mount Sinai Health System, encompassing its eight hospitals and ambulatory footprint.
• In May 2021, Smiths Medical and Ivenix, Inc. announced a partnership to deliver a comprehensive range of infusion management solutions to the U.S. market. The goal of this partnership is to enhance infusion administration and patient safety.
• In January 2021, Amedisys collaborated with Option Care Health to deliver COVID-19 infusion therapy to the Vulnerable population.
• In March 2020, KabaFusion, a leading provider of specialty acute and chronic home infusion therapies, announced that it has acquired the home infusion assets of Lincare, a subsidiary of Linde plc.

By Product - Global Home Infusion Therapy Market and Forecast

Based on product, the home infusion therapy market is segmented into infusion pumps, intravenous sets, IV cannulas, and needleless connectors. In 2021, Infusion pumps dominated the market with over 50% share of the total market. This can be attributed to their increasing use and efficiency in delivering nutrition, medications, and other required fluids into a patient’s body in a controlled manner. Nowadays, smart pumps are widely used as these pumps contain advanced features such as barcode technology, which helps in the verification of a patient’s identity and prevents drug administration errors. Needleless connectors is expected to be the fastest-growing segment over the forecast period owing to various benefits, such as less risk of bacterial contamination and higher protection against needlestick injuries. These connectors offer improved safety, enable smooth surgeries, and help adhere to good clinical practice (GCP), which contributes to the growth of the segment.

By Application - Global Home Infusion Therapy Market and Forecast

Based on application, the anti-infective segment held over a quarter of the market in 2021 impelled by the benefits provided by the anti-infective infusion therapy treatment. This intravenous infusion of antifungal, antiviral, or antibiotic drugs is highly used to treat infections that do not respond to oral therapeutics, thereby significantly driving the industry value. The enteral nutrition segment accounted for second highest share of the total home infusion therapy market in 2021. The enteral nutrition should be used in patients who cannot meet their nutrient requirements by oral intake, yet have a functional gastrointestinal (GI) tract, and who are able to receive therapy outside of an acute care setting. It is estimated that around 400,000 people of all ages in the US are receiving enteral nutrition at home. Chemotherapy is the fastest growing application for home infusion therapy market. With the growing incidences of cancer, the demand for pressure pumps is expected to increase in the coming years. Pumps used for chemotherapy at home are compact, continuous pressure pumps that do not require a battery and can hence be used for a longer period of time.

By Region - Global Home Infusion Therapy Market and Forecast

On regional basis, North America dominates the home infusion therapy market in 2021 and this trend is expected to continue throughout the forecast period. Europe is projected to gain substantial growth due to the increasing burden of chronic diseases and the expanding geriatric population. Additionally, growing government initiatives are expected to fuel the growth of the regional home infusion therapy market. Asia Pacific is expected to register the fastest growth over the forecast period. This is attributed to rising patient awareness regarding the benefits of home infusion therapy over in-hospital procedures and the growing prevalence of diabetes in the region.

The research report titled “Global Home Infusion Therapy Market (By Product, Application, Region), Impact of COVID-19, Key Company Profiles, Trends and Recent Developments - Forecast to 2028” provides a comprehensive analysis of the Global Home Infusion Therapy Market.

This 165 Page report with 34 Figures and 20 Tables has been analyzed from 9 View Points:
1) Global - Home Infusion Therapy Market and Forecast (2015 – 2028)
2) Impact of COVID-19 on Home Infusion Therapy Market
3) Global - Home Infusion Therapy Market Share and Forecast (2015 – 2028)
4) By Product - Global Home Infusion Therapy Market and Forecast (2015 – 2028)
5) By Application - Global Home Infusion Therapy Market and Forecast (2015 – 2028)
6) By Region - Global Home Infusion Therapy Market and Forecast (2015 – 2028)
7) Global Home Infusion Therapy Market – Recent Developments
8) Global Home Infusion Therapy Market - Growth Drivers & Challenges
9) Global Home Infusion Therapy Market – Key Company Profiles, Financials, Recent Developments

By Product - Global Home Infusion Therapy Market and Forecast
• Infusion Pump
• Intravenous Sets
• IV Cannulas
• Needleless Connectors

By Application - Global Home Infusion Therapy Market and Forecast
• Anti-infective
• Enteral Nutrition
• Parenteral Nutrition
• Specialty Pharmaceuticals
• Chemotherapy
• Hydration Therapy
• Others

By Region - Global Home Infusion Therapy Market and Forecast
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Global Home Infusion Therapy Market – Key Company Profiles
1. B. Braun Melsungen AG
2. Eli Lilly
3. Becton, Dickinson and Company
4. Baxter International Inc.
5. Smiths Medical (Now Part of ICU Medical)
6. Terumo Corporation
7. ICU Medical
8. CVS/Coram
9. Option Care Health
10. BriovaRx / OptumRx/ Diplomat (UnitedHealth Group)
11. PharMerica
12. Fresenius Kabi
13. JMS Co. Ltd.
14. PharmaScript
15. CareCentrix, Inc.
16. PromptCare
17. Infusystem
18. AIS Healthcare
19. Altus Biologics
20. ContinuumRX
21. FlexCare Infusion Centers
22. Healix
23. KabaFusion
24. InfuCare Rx
25. Palmetto Infusion

Data Source

The analyst employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

Companies Mentioned
1. B. Braun Melsungen AG
2. Eli Lilly
3. Becton, Dickinson and Company
4. Baxter International Inc.
5. Smiths Medical (Now Part of ICU Medical)
6. Terumo Corporation
7. ICU Medical
8. CVS/Coram
9. Option Care Health
10. BriovaRx / OptumRx/ Diplomat (UnitedHealth Group)
11. PharMerica
12. Fresenius Kabi
13. JMS Co. Ltd.
14. PharmaScript
15. CareCentrix, Inc.
16. PromptCare
17. Infusystem
18. AIS Healthcare
19. Altus Biologics
20. ContinuumRX
21. FlexCare Infusion Centers
22. Healix
23. KabaFusion
24. InfuCare Rx
25. Palmetto Infusion

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

mRNA Vaccines and Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • $ 4750
  • December 2022
  • 156 pages

The mRNA vaccines and therapeutics market is expected to register a CAGR of 7.2% over the forecast period (2022-2027). While the sudden outbreak of the COVID-19 pandemic negatively affected most business ...

  • World
  • Therapy
  • Industry analysis
  • Cancer Incidence
  • HIV AIDS Prevalence

ref:plp2022

Reportlinker.com © Copyright 2023. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on